Has SLT study shed new light on treating eye conditions? (C-100422)
Graham Clews reports on the potential impact of SLT, as a study finds it could reduce the need for traditional treatments for glaucoma or ocular hypertension.
Domains covered
Communication
Clinical practice
Drops first, laser treatment second, and surgery third. That’s been the traditional treatment pathway for glaucoma or ocular hypertension.
Around eight million prescriptions for medications, generally eye drops, are written in the UK each year for this condition and are often effective (Connor and Fraser, 2014). Around a third of UK patients need more than one type of drop (Moorfields, 2015) and long-term use is associated with significant side effects (Waterman et al, 2013).
Irritation, red eyes, iris colour changes, and hyperpigmentation of eyelid skin can all lead patients to leave drops unused, and non-compliance rates can be as high as 50% (NICE, 2017a).
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
The number of people with glaucoma, AMD and cataracts is set to increase over the next 10 years. This new online tool will be a critical planning resource for commissioners and providers of eye health care.
In this live webinar, Ms Nishani Amerasinghe, a Consultant Ophthalmic Surgeon, will give an overview of PAC, PACG and PACS.
This paper reviews the history and current use of the lissamine green dye in ocular examination.